1. Home
  2. LFST vs SRPT Comparison

LFST vs SRPT Comparison

Compare LFST & SRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LifeStance Health Group Inc.

LFST

LifeStance Health Group Inc.

HOLD

Current Price

$10.10

Market Cap

2.9B

Sector

Health Care

ML Signal

HOLD

Logo Sarepta Therapeutics Inc. (DE)

SRPT

Sarepta Therapeutics Inc. (DE)

HOLD

Current Price

$16.17

Market Cap

2.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LFST
SRPT
Founded
2015
1980
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Nursing Services
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.9B
2.5B
IPO Year
2021
2000

Fundamental Metrics

Financial Performance
Metric
LFST
SRPT
Price
$10.10
$16.17
Analyst Decision
Strong Buy
Hold
Analyst Count
6
29
Target Price
$9.83
$25.85
AVG Volume (30 Days)
2.8M
2.8M
Earning Date
05-07-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
2.88
Revenue
$1,424,285,000.00
$2,198,237,000.00
Revenue This Year
$17.18
N/A
Revenue Next Year
$14.02
N/A
P/E Ratio
N/A
$5.56
Revenue Growth
13.85
15.58
52 Week Low
$3.74
$10.42
52 Week High
$10.00
$25.32

Technical Indicators

Market Signals
Indicator
LFST
SRPT
Relative Strength Index (RSI) 78.65 43.75
Support Level $6.23 $15.10
Resistance Level N/A $18.16
Average True Range (ATR) 0.33 0.79
MACD 0.17 0.18
Stochastic Oscillator 97.66 42.57

Price Performance

Historical Comparison
LFST
SRPT

About LFST LifeStance Health Group Inc.

LifeStance Health Group Inc is a mental healthcare company that operates as a provider of outpatient mental health services, spanning psychiatric evaluations and treatment, psychological and neuropsychological testing, and individual, family, and group therapy. It treats a broad range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder, using evidence-based approaches to ensure effective treatment. The group has a single operating and reportable segment of mental health services.

About SRPT Sarepta Therapeutics Inc. (DE)

Sarepta Therapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, gene therapies, and other genetic medicines for rare diseases, particularly neuromuscular disorders. The company has developed approved treatments for Duchenne muscular dystrophy, including EXONDYS 51, VYONDYS 53, AMONDYS 45, and ELEVIDYS, and is advancing additional therapeutic candidates for neuromuscular and other rare diseases. The company operates in one segment: discovering, developing, manufacturing, and delivering therapies to patients with rare diseases.

Share on Social Networks: